Catalent provides end-to-end solutions to accelerate drug development programmes and with the addition of Micron Technologies’ particle size engineering capabilities, now has the broadest bioavailability solutions toolkit in the industry.
Catalent Micron Technologies - Enhanced bioavailability.Proven Results.
With the addition of Micron Technologies’ particle-size engineering expertise and experience, Catalent can support clients at the earliest stages of the drug development process, and provide end-to-end solutions to accelerate programmes to the clinic and market with the broadest bioavailability solutions toolkit in the industry. Micronization has many benefits, and is typically the first choice technology to improve the solubility performance of the product:
Catalent Micron Technologies is the leading global provider for the most complex, specialised requirements in micronization, with the expertise to handle your toughest specifications. Micronization is used across most solid oral dosage types and inhalation delivery technologies to address increasing drug performance challenges.
Capabilities in particle size engineering include:
more products. better treatments. reliably supplied.™
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.